Clear Street: Gilead Deal Highlights Huge Potential in Cullinan’s Pipeline
Gilead’s up to $2.2B acquisition of Ouro Medicines highlights strong potential for Cullinan Therapeutics’ velinotamig. Clear Street maintains Buy rating with $33 PT.
NOTRELOAD AI
Vertiv Boosts AI Cooling Power with ThermoKey Acquisition and Major Factory Expansions
Vertiv agrees to acquire Italian cooling specialist ThermoKey, expanding its thermal management portfolio for high-density AI data centers. Vertiv also announces major factory expansions in the Americas to meet surging AI demand.
Arm Enters the AI Chip War: Launches Its First-Ever AGI CPU with Meta as Lead Customer
Arm enters the AI chip race with its new 136-core AGI CPU. Meta is the first major buyer as Arm targets $15B annual revenue from chips in 5 years — aiming for $25B total company sales.
Etsy Faces Headwinds as Rising Gas Prices Hit Discretionary Spending
Oppenheimer lowers Etsy’s first-half sales estimates due to higher gas prices and plateauing buyers. Shares fall sharply.
Wall Street Goes Bullish on Sutro Biopharma: Two Major Upgrades After Q4 Results
Wells Fargo upgrades to Overweight with $27 PT and H.C. Wainwright raises to Buy with $28 target on strong STRO-004 progress.
Circle Stock Drops as Clarity Act Limits Stablecoin Rewards
Circle Internet stock plunged after the latest Clarity Act draft banned rewards on stablecoin balances. Narrow yield rules spark sell-off.